- Home
- CLDI vs RCG Comparison
CLDI vs RCG Comparison
Compare CLDI & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- RCG
- Stock Information
- Founded
- CLDI 2014
- RCG 1994
- Country
- CLDI United States
- RCG United States
- Employees
- CLDI N/A
- RCG N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- RCG Investment Managers
- Sector
- CLDI Health Care
- RCG Finance
- Exchange
- CLDI Nasdaq
- RCG Nasdaq
- Market Cap
- CLDI 20.2M
- RCG 18.2M
- IPO Year
- CLDI N/A
- RCG N/A
- Fundamental
- Price
- CLDI $1.76
- RCG $2.65
- Analyst Decision
- CLDI
- RCG
- Analyst Count
- CLDI 0
- RCG 0
- Target Price
- CLDI N/A
- RCG N/A
- AVG Volume (30 Days)
- CLDI 1.1M
- RCG 5.9K
- Earning Date
- CLDI 08-08-2025
- RCG 01-01-0001
- Dividend Yield
- CLDI N/A
- RCG 0.98%
- EPS Growth
- CLDI N/A
- RCG N/A
- EPS
- CLDI N/A
- RCG N/A
- Revenue
- CLDI N/A
- RCG N/A
- Revenue This Year
- CLDI N/A
- RCG N/A
- Revenue Next Year
- CLDI N/A
- RCG N/A
- P/E Ratio
- CLDI N/A
- RCG N/A
- Revenue Growth
- CLDI N/A
- RCG N/A
- 52 Week Low
- CLDI $1.61
- RCG $1.52
- 52 Week High
- CLDI $46.68
- RCG $1.90
- Technical
- Relative Strength Index (RSI)
- CLDI 29.56
- RCG 53.33
- Support Level
- CLDI $1.61
- RCG $2.57
- Resistance Level
- CLDI $6.06
- RCG $2.69
- Average True Range (ATR)
- CLDI 0.77
- RCG 0.09
- MACD
- CLDI -0.55
- RCG 0.00
- Stochastic Oscillator
- CLDI 2.57
- RCG 78.95
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About RCG RENN Fund Inc
RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.